Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) price on current trading day, fall -5.81% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $2.43.
A look at the stock’s price movement, the close in the last trading session was $2.58, moving within a range at $2.25 and $2.67. Turning to its 52-week performance, $11.56 and $2.37 were the 52-week high and 52-week low respectively. Overall, MRVI moved -40.73% over the past month.
Maravai LifeSciences Holdings Inc’s market cap currently stands at around $613.64 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-17.
Analysts have a consensus estimate of 62.82M for the company’s revenue for the quarter, with a low and high estimate of 57M and 66.4M respectively. The average forecast suggests down to a -2.12% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 266.52M, representing a 2.83% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that MRVI is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
7 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 6 recommend MRVI as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
MRVI’s current price about -18.54% and -41.42% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 29.49, while 7-day volatility ratio is 10.10% and 9.69% in the 30-day chart. Further, Maravai LifeSciences Holdings Inc (MRVI) has a beta value of 0.11, and an average true range (ATR) of 0.30. Analysts have given the company’s stock an average 52-week price target of $22, forecast between a low of $10 and high of $25. Looking at the price targets, the low is -311.52% off current price level while to achieve the yearly target high, price needs to move -928.81%. Nonetheless, investors will most likely welcome a -805.35% jump to $22 which is the analysts’ median price.
If we refocus on Maravai LifeSciences Holdings Inc (NASDAQ:MRVI), historical trading data shows that trading volumes averaged 3.28 over the past 10 days and 2.86 million over the past 3 months. The company’s latest data on shares outstanding shows there are 141.59 million shares.
The 16.89% of Maravai LifeSciences Holdings Inc’s shares are in the hands of company insiders while institutional holders own 86.81% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 8.82 million on 2025-02-28, giving us a short ratio of 2.49. The data shows that as of 2025-02-28 short interest in Maravai LifeSciences Holdings Inc (MRVI) stood at 742.00004 of shares outstanding, with shares short rising to 8.54 million registered in 2025-01-31. Current price change has pushed the stock -55.41% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the MRVI stock continues to rise going into the next quarter.
